Position in MRK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,242,504
+$1,842,716 QoQ
Shares Held
64,144
+20.6% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.75%
of 13F equity value
Holder Rank
#820
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ALERUS FINANCIAL NA holds $65,318,341 across 13 Drug Manufacturers - General names. MRK ranks #4 (12.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
16,766 | $20,109,645 | |
| 2 | JNJ |
Johnson & Johnson
|
74,659 | $18,961,146 | |
| 3 | ABBV |
AbbVie Inc.
|
48,063 | $12,094,573 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
64,144 | $8,242,504 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
42,984 | $2,476,738 | |
| 6 | PFE |
Pfizer Inc
|
87,204 | $2,099,872 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
9,022 | $1,139,839 | |
| 8 | AZN |
Astrazeneca PLC
|
586 | $111,117 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,242,504 | 64,144 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $6,399,788 | 53,203 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $4,148,928 | 39,416 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $796,663 | 9,492 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $776,717 | 9,812 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $906,576 | 10,100 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,027,230 | 10,326 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $5,895,808 | 51,918 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $6,399,222 | 51,690 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $8,886,700 | 67,349 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $7,387,195 | 67,760 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $6,864,911 | 66,682 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $8,374,429 | 72,575 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $7,762,108 | 72,959 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $7,993,836 | 72,049 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $6,782,552 | 78,757 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,979,428 | 76,554 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $7,419,781 | 90,430 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $5,501,219 | 71,780 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,724,179 | 49,583 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,742,992 | 48,129 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $3,463,347 | 44,926 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $3,956,091 | 48,363 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $3,749,424 | 45,201 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $8,181,362 | 105,798 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $8,997,513 | 116,942 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||